Efficacy and Safety Study of Mepolizumab 100 Milligram (mg) Subcutaneous (SC) in Indian Participants Aged Greater Than or Equal to (>=) 18 Years With Severe Eosinophilic Asthma
Clinical trial NCT04276233 · COMPLETED
Trial details
- NCT number
- NCT04276233
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-29
- Primary completion
- 2023-10-28
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.